Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 6 studies | 27% ± 8% | |
| astrocyte | 4 studies | 28% ± 9% | |
| endothelial cell | 3 studies | 22% ± 7% | |
| microglial cell | 3 studies | 20% ± 3% | |
| epithelial cell | 3 studies | 21% ± 5% | |
| macrophage | 3 studies | 21% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 2482.88 | 459 / 459 | 99% | 6.70 | 1107 / 1118 |
| brain | 100% | 1348.13 | 2634 / 2642 | 99% | 4.69 | 698 / 705 |
| prostate | 100% | 1879.56 | 245 / 245 | 99% | 4.09 | 495 / 502 |
| esophagus | 100% | 1545.64 | 1439 / 1445 | 98% | 3.30 | 180 / 183 |
| thymus | 100% | 2632.31 | 653 / 653 | 97% | 3.16 | 586 / 605 |
| lung | 100% | 2596.16 | 578 / 578 | 94% | 3.24 | 1085 / 1155 |
| pancreas | 98% | 942.93 | 323 / 328 | 94% | 2.78 | 168 / 178 |
| skin | 100% | 2081.04 | 1808 / 1809 | 91% | 4.07 | 431 / 472 |
| kidney | 100% | 1642.42 | 89 / 89 | 91% | 3.30 | 819 / 901 |
| uterus | 100% | 2500.72 | 170 / 170 | 89% | 2.65 | 410 / 459 |
| liver | 99% | 810.48 | 223 / 226 | 90% | 2.38 | 365 / 406 |
| ovary | 100% | 2613.41 | 180 / 180 | 88% | 2.16 | 380 / 430 |
| adrenal gland | 100% | 1492.14 | 257 / 258 | 86% | 2.15 | 197 / 230 |
| bladder | 100% | 1868.76 | 21 / 21 | 79% | 2.27 | 399 / 504 |
| stomach | 99% | 1235.54 | 357 / 359 | 80% | 1.90 | 228 / 286 |
| intestine | 100% | 1838.79 | 965 / 966 | 71% | 1.48 | 373 / 527 |
| spleen | 100% | 3300.58 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.92 | 1 / 1 |
| adipose | 100% | 2478.69 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2049.83 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 97% | 913.38 | 782 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 2090.99 | 897 / 929 | 0% | 0 | 0 / 0 |
| heart | 96% | 1268.38 | 827 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 1.84 | 38 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 2.53 | 24 / 29 |
| eye | 0% | 0 | 0 / 0 | 70% | 1.92 | 56 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0002682 | Biological process | regulation of immune system process |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0001817 | Biological process | regulation of cytokine production |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZBTB37 |
| Protein name | Zinc finger and BTB domain-containing protein 37 |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000695459.1 [Q5TC79-1] ENST00000367702.1 [Q5TC79-2] Q5TC79 ENST00000367701.10 [Q5TC79-1] ENST00000367704.5 [Q5TC79-3] |
